Log In
Print
BCIQ
Print
Print this Print this
 

Tivopath, tivozanib (ASP4130, AV-951) (formerly KRN951)

  Manage Alerts
Collapse Summary General Information
Company Kyowa Hakko Kirin Co. Ltd.
DescriptionInhibitor of VEGF receptors 1, 2 and 3
Molecular Target Vascular endothelial growth factor (VEGF)
Mechanism of ActionVascular endothelial growth factor (VEGF) inhibitor
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today